Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Decibel Therapeutics Inc.

    NASDAQ: DBTX · Real-Time Price · USD
    4.91
    -0.04 (-0.81%)
    At close: Sep 22, 2023, 10:00 PM

    Decibel Therapeutics Statistics

    Share Statistics

    Decibel Therapeutics has 25.13M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 25.13M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 13.4M

    Failed to Deliver (FTD) Shares

    n/a
    		 14,291

    FTD / Avg. Volume

    n/a
    		 6.66%

    Short Selling Information

    The latest short interest is 110.95K, so 0.44% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 110.95K

    Short % of Shares Out

    n/a
    		 0.44%

    Short % of Float

    n/a
    		 0.65%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.81 and the forward PE ratio is null. Decibel Therapeutics's PEG ratio is -0.14.

    PE Ratio

    n/a
    		 -0.81

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.63

    P/FCF Ratio

    n/a
    		 -0.89

    PEG Ratio

    n/a
    		 -0.14
    Financial Ratio History

    Enterprise Valuation

    Decibel Therapeutics has an Enterprise Value (EV) of 30.61M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.49

    EV / EBIT

    n/a
    		 -0.54

    EV / FCF

    n/a
    		 -0.53

    Financial Position

    The company has a current ratio of 4.81, with a Debt / Equity ratio of 0.17.

    Current Ratio

    n/a
    		 4.81

    Quick Ratio

    n/a
    		 4.81

    Debt / Equity

    n/a
    		 0.17

    Debt / EBITDA

    n/a
    		 -0.22

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 -53.66

    Financial Efficiency

    Return on Equity is -77.03% and Return on Invested Capital is -66.98%.

    Return on Equity

    n/a
    		 -77.03%

    Return on Assets

    n/a
    		 -51.07%

    Return on Invested Capital

    n/a
    		 -66.98%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-926,544.12

    Employee Count

    n/a
    		 68

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 240K

    Effective Tax Rate

    n/a
    		 -0.38%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is -0.4, so Decibel Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.4

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 4.61

    200-Day Moving Average

    n/a
    		 3.72

    Relative Strength Index (RSI)

    n/a
    		 51.68

    Average Volume (20 Days)

    n/a
    		 214,738

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -63.96M

    Net Income

    n/a
    		 -63.01M

    EBITDA

    n/a
    		 -62.49M

    EBIT

    n/a
    		 -61.57M

    Earnings Per Share (EPS)

    n/a
    		 -2.52
    Full Income Statement

    Balance Sheet

    The company has 34.61M in cash and 14.05M in debt, giving a net cash position of 20.55M.

    Cash & Cash Equivalents

    n/a
    		 34.61M

    Total Debt

    n/a
    		 14.05M

    Net Cash

    n/a
    		 20.55M

    Retained Earnings

    n/a
    		 -277.52M

    Total Assets

    n/a
    		 94.39M

    Working Capital

    n/a
    		 53.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -56.9M and capital expenditures -463K, giving a free cash flow of -57.36M.

    Operating Cash Flow

    n/a
    		 -56.9M

    Capital Expenditures

    n/a
    		 -463K

    Free Cash Flow

    n/a
    		 -57.36M

    FCF Per Share

    n/a
    		 -2.3
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DBTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -123.13%

    FCF Yield

    n/a
    		 -112.1%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for DBTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.4

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist